Index | RUT |
Market Cap | 952.66M |
Enterprise Value | 720.10M |
Income | - |
Sales | - |
Book/sh | 6.95 |
Cash/sh | 7.00 |
Dividend Est. | - |
Dividend TTM | - |
Dividend Ex-Date | - |
Dividend Gr. 3/5Y | - - |
Payout | - |
Employees | 65 |
IPO | Feb 06, 2026 |
P/E | - |
Forward P/E | - |
PEG | - |
P/S | - |
P/B | 4.10 |
P/C | 4.07 |
P/FCF | - |
EV/EBITDA | - |
EV/Sales | - |
Quick Ratio | 25.06 |
Current Ratio | 25.06 |
Debt/Eq | 0.01 |
LT Debt/Eq | 0.01 |
Option/Short | No / Yes |
EPS (ttm) | - |
EPS next Y | -2.81 |
EPS next Q | -0.62 |
EPS this Y | 86.10% |
EPS next Y | -12.63% |
EPS next 5Y | 44.60% |
EPS past 3/5Y | -69.04% - |
Sales past 3/5Y | - - |
EPS Y/Y TTM | - |
Sales Y/Y TTM | - |
EPS Q/Q | 84.99% |
Sales Q/Q | - |
| |
| |
Insider Own | 58.24% |
Insider Trans | 0.00% |
Inst Own | 40.59% |
Inst Trans | 2.86% |
ROA | - |
ROE | - |
ROIC | - |
Gross Margin | - |
Oper. Margin | - |
Profit Margin | - |
SMA20 | 11.90% |
SMA50 | 6.73% |
SMA200 | 17.88% |
Trades | |
Shs Outstand | 33.45M |
Shs Float | 13.97M |
| |
| |
| |
52W High | 32.44 -12.21% |
52W Low | 17.06 66.94% |
Volatility | 7.10% 5.94% |
ATR (14) | 1.53 |
RSI (14) | 62.88 |
Beta | - |
Rel Volume | 0.71 |
Avg Volume | 99.36K |
Volume | 70,599 |
Perf Week | 18.67% |
Perf Month | 3.00% |
Perf Quarter | 36.79% |
Perf Half Y | 21.09% |
Perf YTD | 18.67% |
Perf Year | - |
Perf 3Y | - |
Perf 5Y | - |
Perf 10Y | - |
| |
| |
Prev Close | 28.22 |
Price | 28.48 |
Change % | 0.92% |
|
 |
|
|
|
| |
| Date |
Action |
Analyst |
Rating Change |
Price Target Change |
| Aug-14-26 | Initiated |
Raymond James |
Outperform |
$39 |
| Mar-10-26 | Initiated |
H.C. Wainwright |
Buy |
$37 |
| Mar-03-26 | Initiated |
Stifel |
Buy |
$42 |
| Mar-03-26 | Initiated |
Leerink Partners |
Outperform |
$42 |
| Mar-03-26 | Initiated |
Jefferies |
Buy |
$62 |
| Mar-03-26 | Initiated |
Citigroup |
Buy |
$42 |
|
|
|
Oct-19-26 08:00AM
|
|
|
Oct-01-26 08:00AM
|
|
|
Aug-06-26 04:05PM
|
|
|
Jun-15-26 08:00AM
|
|
|
Jun-02-26 08:00AM
|
|
| 08:00AM |
Loading… |
|
May-21-26 08:00AM
|
|
|
May-18-26 08:00AM
|
|
|
May-14-26 04:05PM
|
|
|
Mar-26-26 04:05PM
|
|
|
Mar-09-26 08:00AM
|
|
|
Mar-04-26 08:00AM
|
|
|
Mar-03-26 09:33AM
|
|
|
08:00AM
|
|
|
Feb-16-26 08:40AM
|
|
|
Feb-09-26 04:05PM
|
|
| |
|
|
| |
|
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| RA CAPITAL MANAGEMENT, L.P. | Director | Feb 09 '26 | Buy | 16.00 | 3,690,000 | 59,040,000 | 5,966,439 | Feb 11 05:15 PM | | Behbahani Ali | Director | Feb 09 '26 | Buy | 16.00 | 937,500 | 15,000,000 | 6,035,038 | Feb 11 04:30 PM | | Florence Anthony A. Jr. | 10% Owner | Feb 09 '26 | Buy | 16.00 | 937,500 | 15,000,000 | 6,035,038 | Feb 11 04:30 PM | | BASKETT FOREST | 10% Owner | Feb 09 '26 | Buy | 16.00 | 937,500 | 15,000,000 | 6,035,038 | Feb 11 04:30 PM | | New Enterprise Associates 17, | 10% Owner | Feb 09 '26 | Buy | 16.00 | 937,500 | 15,000,000 | 6,035,038 | Feb 11 04:30 PM | | Yang Rick | 10% Owner | Feb 09 '26 | Buy | 16.00 | 937,500 | 15,000,000 | 6,035,038 | Feb 11 04:30 PM | | Makhzoumi Mohamad | 10% Owner | Feb 09 '26 | Buy | 16.00 | 937,500 | 15,000,000 | 6,035,038 | Feb 11 04:30 PM | | SANDELL SCOTT D | 10% Owner | Feb 09 '26 | Buy | 16.00 | 937,500 | 15,000,000 | 6,035,038 | Feb 11 04:30 PM | | Chang Carmen | 10% Owner | Feb 09 '26 | Buy | 16.00 | 937,500 | 15,000,000 | 6,035,038 | Feb 11 04:30 PM | | Walker Paul Edward | 10% Owner | Feb 09 '26 | Buy | 16.00 | 937,500 | 15,000,000 | 6,035,038 | Feb 11 04:30 PM | | Mathers Edward T | 10% Owner | Feb 09 '26 | Buy | 16.00 | 937,500 | 15,000,000 | 6,035,038 | Feb 11 04:30 PM | | Pardo Geoffrey B | Director | Feb 09 '26 | Buy | 16.00 | 312,500 | 5,000,000 | 2,187,513 | Feb 11 04:09 PM | | Khan Bilal Arshad | Director | Feb 09 '26 | Buy | 16.00 | 115,000 | 1,840,000 | 251,427 | Feb 11 04:07 PM | | Khan Bilal Arshad | Director | Feb 09 '26 | Buy | 16.00 | 20,000 | 320,000 | 25,450 | Feb 11 04:07 PM | | Nielsen Kirk G. | Director | Feb 09 '26 | Buy | 16.00 | 165,000 | 2,640,000 | 3,310,619 | Feb 10 06:09 PM | | Vensana Capital I GP, LLC | 10% Owner | Feb 09 '26 | Buy | 16.00 | 165,000 | 2,640,000 | 3,310,619 | Feb 10 06:08 PM |
|
|
SpyGlass Pharma, Inc. is a late-stage biopharmaceutical, which engages in the development of treatment paradigm for patients living with chronic eye conditions. Its lead product candidate, Bimatoprost Drug Pad-IOL System (BIM-IOL System), is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) for patients who have wither open-angel glaucoma (OAG) or ocular hypertension (OHT). The company was founded in January 2019 by Malik Y. Kahook and Glenn Sussman and is headquartered in Aliso Viejo, CA. | |
|
| Co-FounderDr. Malik Y. Kahook M.D. CEO & DirectorMr. Patrick H. Mooney Chief Research & Development OfficerDr. Chetan Pujara Ph.D. Co-founder & Chief Technology AdvisorMr. Glenn Sussman Chief Financial OfficerDr. Jean-Frederic Viret Ph.D. |
|
|
|
S